These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14506015)

  • 1. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans.
    Joukhadar C; Stass H; Müller-Zellenberg U; Lackner E; Kovar F; Minar E; Müller M
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3099-103. PubMed ID: 14506015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.
    Majcher-Peszynska J; Sass M; Schipper S; Czaika V; Gussmann A; Lobmann R; Mundkowski RG; Luebbert C; Kujath P; Ruf BR; Koch H; Schareck W; Klar E; Drewelow B;
    Eur J Clin Pharmacol; 2011 Feb; 67(2):135-42. PubMed ID: 20871984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of moxifloxacin into peripheral compartments in humans.
    Müller M; Stass H; Brunner M; Möller JG; Lackner E; Eichler HG
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2345-9. PubMed ID: 10508004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue pharmacokinetics of levofloxacin in human soft tissue infections.
    Bellmann R; Kuchling G; Dehghanyar P; Zeitlinger M; Minar E; Mayer BX; Müller M; Joukhadar C
    Br J Clin Pharmacol; 2004 May; 57(5):563-8. PubMed ID: 15089808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW; Ward KW
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.
    Fernández-Varón E; Villamayor L; Escudero E; Espuny A; Cárceles CM
    Vet J; 2006 Sep; 172(2):302-7. PubMed ID: 15908243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.
    Kees MG; Weber S; Kees F; Horbach T
    J Antimicrob Chemother; 2011 Oct; 66(10):2330-5. PubMed ID: 21729931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.
    Cárceles CM; Villamayor L; Escudero E; Marín P; Fernández-Varón E
    Vet J; 2007 Mar; 173(2):452-5. PubMed ID: 16377219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.
    Burkhardt O; Derendorf H; Jäger D; Kumar V; Madabushi R; Röhl K; Barth J
    Scand J Infect Dis; 2006; 38(10):904-8. PubMed ID: 17008236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
    Lindstrom R; Lane S; Cottingham A; Smith S; Sall K; Silverstein S; Shettle L; Walters T; Faulkner R; Cockrum P; Teuscher N
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
    Wacke R; Förster S; Adam U; Mundkowski RG; Klar E; Hopt UT; Drewelow B
    J Antimicrob Chemother; 2006 Nov; 58(5):994-9. PubMed ID: 16956903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.
    Landersdorfer CB; Kinzig M; Hennig FF; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F; Gusinde J
    Antimicrob Agents Chemother; 2009 May; 53(5):2074-81. PubMed ID: 19223648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
    Rink AD; Stass H; Delesen H; Kubitza D; Vestweber KH
    Clin Drug Investig; 2008; 28(2):71-9. PubMed ID: 18211115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.
    Pathania R; Sharma SK
    Res Vet Sci; 2010 Aug; 89(1):108-12. PubMed ID: 20202656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Breilh D; Jougon J; Djabarouti S; Gordien JB; Xuereb F; Velly JF; Arvis P; Landreau V; Saux MC
    J Chemother; 2003 Dec; 15(6):558-62. PubMed ID: 14998080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
    Burkhardt O; Stass H; Thuss U; Borner K; Welte T
    Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of moxifloxacin into liver tissue.
    Justinger C; Schilling MK; Kees MG; Kauffels A; Hirschmann K; Kopp B; Kees F; Kollmar O
    Int J Antimicrob Agents; 2012 Jun; 39(6):505-9. PubMed ID: 22526014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinus tissue concentration of moxifloxacin after a single oral dose.
    Dinis PB; Monteiro MC; Martins ML; Silva N; Morais JG
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):142-6. PubMed ID: 14994771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.